Prosecution Insights
Last updated: October 04, 2026
Application No. 18/256,757

IMPLANT AND ASSEMBLY HAVING A RADIATION SOURCE AND AN IMPLANT

Final Rejection §112
Filed
Jun 09, 2023
Priority
Dec 22, 2020 — DE 10 2020 134 541.0 +1 more
Examiner
SHOULDERS, ANNIE LEE
Art Unit
3794
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Rheinisch-Westfälische Technische Hochschule Aachen
OA Round
2 (Final)
75%
Grant Probability
Favorable
3-4
OA Rounds
2m
Est. Remaining
92%
With Interview

Examiner Intelligence

Grants 75% — above average
75%
Career Allowance Rate
156 granted / 209 resolved
+4.6% vs TC avg
Strong +18% interview lift
Without
With
+17.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
44 currently pending
Career history
242
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
59.6%
+19.6% vs TC avg
§102
17.8%
-22.2% vs TC avg
§112
15.4%
-24.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 209 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status 1. The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . 2. In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. Claim Rejections - 35 USC § 112 3. The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. 4. Claim 6 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. 5. Claim 6 recites being dependent upon claim 5. However, claim 5 has been cancelled. Therefore, claim 6 is rendered indefinite. Proper correction is required. Allowable Subject Matter 6. Claims 1, 3, 4, 7, 8-11, and 13-15 are allowed. The following is an examiner’s statement of reasons for allowance: an implant for implanting in a hollow organ or a vessel of a body, wherein the implant is composed of a filament that comprises at least one polymeric matrix material in which a magnetically heatable filler is arranged is well known in the art. This is supported by at least the references cited during the prosecution of this case, as well as other references in the general area that could be located with minimal effort. However, the prior art of record fails to specifically teach the filament having a cross section with a core-sheath structure characterized in that the core forms a polymeric reinforcing structure, and in that the sheath comprises the polymeric matrix material, wherein the core is filamentary and formed from solid material and the sheath has a tubular structure formed around the core, and wherein the implant is a textile stent having a braided structure. The prior art also fails to provide sufficient motivation to make such specific modifications and would require improper use of hindsight to arrive at the claimed invention when considered along or in any proper combination. 7. Claim 6 would be allowable if rewritten to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action and to include all of the limitations of the base claim and any intervening claims. Conclusion 8. THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. /ANNIE L SHOULDERS/Examiner, Art Unit 3794
Read full office action

Prosecution Timeline

Jun 09, 2023
Application Filed
Jan 13, 2026
Non-Final Rejection mailed — §112
May 11, 2026
Response Filed
Aug 10, 2026
Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12702473
SYSTEMS FOR IMPROVING THE APPEARANCE OF TISSUE
4y 0m to grant Granted Aug 11, 2026
Patent 12702476
FORCE SENSING CATHETER INCLUDING SEALED ELECTRODE TIP ASSEMBLY AND METHODS OF ASSEMBLING SAME
2y 2m to grant Granted Aug 11, 2026
Patent 12678223
SYSTEMS AND METHODS FOR CYLINDRICAL CAGE MAPPING AND ABLATION CATHETERS HAVING FLEXIBLE CIRCUITS
2y 8m to grant Granted Jul 14, 2026
Patent 12678327
CAPSULOTOMY DEVICE
2y 7m to grant Granted Jul 14, 2026
Patent 12643111
NANO SURFACES ON SMOKE PARTICLE ELECTRODES
3y 7m to grant Granted Jun 02, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
75%
Grant Probability
92%
With Interview (+17.6%)
3y 6m (~2m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 209 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month